The WARNINGS section of the prescribing information for Heparin has been revised. Use of the drug carries the possibility of delayed onset of heparin-induced thrombocytopenia or HIT, a serious condition caused by irreversible aggregation of platelets. The condition may progress to thromboses. Health care providers should evaluate patients for HIT, if they present with thrombocytopenia or thrombosis after discontinuing the use of heparin.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.